Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Thierry Troosters (Glasgow, United Kingdom), Thierry Troosters, Jean Bourbeau, François Maltais, Nancy Leidy, Damijan Erzen, Dorothy De Sousa, Lawrence Korducki, Kim L. Lavoie, Wim Janssens, Alan Hamilton. Effect of 8 and 12 weeks’ once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with COPD. Eur Respir J 2016; 48: Suppl. 60, 976

Member's Comments

No comment yet.

Related content which might interest you: Effects of 12 weeks of once-daily tiotropium and olodaterol fixed-dose combination on exercise endurance in patients with COPD Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Endurance shuttle walking test: responsiveness to salmeterol in COPD Source: Eur Respir J 2008; 31: 579-584 Year: 2008 Tiotropium improves walking endurance in COPD Source: Eur Respir J 2012; 39: 265-271 Year: 2012 Effects of a combination of vilanterol and umeclidinium on exercise endurance in subjects with COPD: Two randomised clinical trials Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Effects of endurance and resistance training as maintenance program after 4 weeks of pulmonary rehabilitation for patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 428s Year: 2003 Effects of inhaled formoterol on dynamic hyperinflation during and after incremental treadmill exercise in patients with advanced COPD Source: Eur Respir J 2006; 28: Suppl. 50, 172s Year: 2006 Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015 Effects of a 6 week whole-body vibration training (WBVT) in stable COPD patients: A randomized clinical trial Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception Year: 2016 Effects of aclidinium bromide on exercise endurance, dynamic hyperinflation, physical activity and exertional dyspnoea in patients with moderate to severe COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Cardiovascular evaluation of tiotropium during constant-work rate exercise in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 49s Year: 2003 Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study Source: ERJ Open Res, 4 (1) 00073-2017; 10.1183/23120541.00073-2017 Year: 2018 Budesonide/formoterol improves exercise tolerance compared with placebo and formoterol in COPD patients Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance Year: 2009 LABA-LAMA combination is superior to LABA monotherapy in improving the cardiocirculatory responses to treadmill exercise in patients with moderate-to-severe COPD Source: Annual Congress 2010 - Exercise in COPD Year: 2010 A systematic review and meta-analysis of the effect of dual versus mono- long-acting bronchodilator therapy on exercise endurance in COPD Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases Year: 2016 Improvement in cycle endurance through comprehensive exercise training in patients with severe COPD Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes Year: 2010 Effect of formoterol on exercise tolerance in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 214s Year: 2004 Degree of exercise limitation in COPD: impact on 6 minute walk (6MW) in response to long-acting β-agonist (LABA) treatment Source: Eur Respir J 2007; 30: Suppl. 51, 76s Year: 2007 Comparing interval and continuous endurance training in COPD Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 Late-breaking abstract: Once-daily NVA237 improves exercise endurance from first dose in patients with COPD: The GLOW3 trial Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease Year: 2011